Iridex CEO Interviewed by The Ophthalmologist

Posted on November 30, 2021 by Scott Shuda

Medical laser company, Iridex (IRIX), CEO David Bruce is interviewed on the company’s proprietary laster treatments for glaucoma.

Iridex is unique in having treatment options across the entire spectrum of glaucoma progression:

More, Iridex’ full-suite of treatment options provides an alternative to a lifetime of expensive drops or invasive surgery.

Disclosure: I am long Iridex and might buy or sell shares at any time.

0 0 votes
Article Rating
Notify of
Inline Feedbacks
View all comments
Would love your thoughts, please comment.x